DS Biopharma
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis (NCT03817190) | DS Biopharma | 2019-09-19 |
Track DS Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.